Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
Add more filters











Publication year range
1.
J Nat Prod ; 87(6): 1574-1581, 2024 Jun 28.
Article in English | MEDLINE | ID: mdl-38789921

ABSTRACT

Natural products represent a rich source of bioactive compounds, covering a large chemical space. Even if challenging, this diversity can be extended by applying chemical modifications. However, these studies generally require multigram amounts of isolated natural products and face frequent testing failures. To overcome this limitation, we propose a rapid and efficient approach that uses molecular networking (MN) to visualize the new chemical diversity generated by simple chemical modifications of natural extracts. Moreover, the strategy deployed enables the most appropriate reagents to be defined quickly upstream of a reaction on a pure compound, in order to maximize chemical diversity. This methodology was applied to the latex extract of Euphorbia dendroides to follow the reactivity toward a series of Brønsted and Lewis acids of three class of diterpene esters identified in this species: jatrophane, terracinolide, and phorbol. Through the molecular networking interpretation, with the aim to illustrate our approach, BF3·OEt2 was selected for chemical modification on isolated jatrophane esters. Three rearranged compounds (3-5) were obtained, showing that the most appropriate reagents can be selected by MN interpretation.


Subject(s)
Biological Products , Diterpenes , Esters , Euphorbia , Plant Extracts , Euphorbia/chemistry , Diterpenes/chemistry , Diterpenes/isolation & purification , Biological Products/chemistry , Plant Extracts/chemistry , Esters/chemistry , Molecular Structure
2.
J Med Chem ; 66(20): 14208-14220, 2023 10 26.
Article in English | MEDLINE | ID: mdl-37795600

ABSTRACT

Schweinfurthins (SWs) are naturally occurring prenylated stilbenes with promising anticancer properties. They act through a novel mechanism of action similar to that of other families of natural compounds. Their known target, oxysterol-binding protein (OSBP), plays a crucial role in controlling the intracellular distribution of cholesterol. We synthesized 15 analogues of SWs and demonstrated for the first time that their cytotoxicity as well as that of natural derivatives correlates with their affinity for OSBP. Through this extensive SAR study, we selected one synthetic analogue obtained in one step from SW-G. Using its fluorescence properties, we showed that this compound recapitulates the effect of natural SW-G in cells and confirmed that it leads to cell death via the same mechanism. Finally, after pilot PK experiments, we provided the first evidence of its in vivo efficacy in combination with temozolomide in a patient-derived glioblastoma xenograft model.


Subject(s)
Oxysterols , Receptors, Steroid , Humans , Receptors, Steroid/metabolism , Cholesterol/metabolism
3.
Molecules ; 27(22)2022 Nov 15.
Article in English | MEDLINE | ID: mdl-36431992

ABSTRACT

Quinoline derivatives and especially quinolones are considered as privileged structures in medicinal chemistry and are often associated with various biological properties. We recently isolated a series of original monoterpenyl quinolones from the bark of Codiaeum peltatum. As this extract was found to have a significant inhibitory activity against a Leishmania species, we decided to study the anti-leishmanial potential of this type of compound. Leishmaniasis is a serious health problem affecting more than 12 million people in the world. Available drugs cause harmful side effects and resistance for some of them. With the aim of finding anti-leishmanial compounds, we developed a synthetic strategy to access natural quinolones and analogues derived from zanthosimuline. We showed the versatility of this natural compound toward cyclization conditions, leading to various polycyclic quinolone-derived structures. The natural and synthetic compounds were evaluated against amastigote forms of Leishmania infantum. The results obtained confirmed the interest of this family of natural compounds but also revealed promising activities for some intermediates deriving from zanthosimuline. Following the same synthetic strategy, we then prepared 14 new analogues. In this work, we identified two promising molecules with good activities against intramacrophage L. infantum amastigotes without any cytotoxicity. We also showed that slight changes in amide functional groups affect drastically their anti-parasitic activity.


Subject(s)
Antiprotozoal Agents , Leishmania infantum , Quinolones , Humans , Antiprotozoal Agents/pharmacology , Antiprotozoal Agents/chemistry , Leishmania infantum/drug effects , Quinolones/pharmacology
4.
Biomed Pharmacother ; 154: 113546, 2022 Oct.
Article in English | MEDLINE | ID: mdl-35988426

ABSTRACT

The overexpression of antiapoptotic members (BCL-2, BCL-xL, MCL-1, etc.) of the BCL-2 family contributes to tumor development and resistance to chemotherapy or radiotherapy. Synthetic inhibitors targeting these proteins have been developed, and some hematological malignancies are now widely treated with a BCL-2 inhibitor (venetoclax). However, acquired resistance to venetoclax or chemotherapy drugs due to an upregulation of MCL-1 has been observed, rendering MCL-1 an attractive new target for treatment. Six MCL-1 inhibitors (S64315, AZD-5991, AMG-176, AMG-397, ABBV-467 and PRT1419) have been evaluated in clinical trials since 2016, but some were affected by safety issues and none are currently used clinically. There is, therefore, still a need for alternative molecules. We previously described two drimane derivatives as the first covalent BH3 mimetics targeting MCL-1. Here, we described the characterization and biological efficacy of one of these compounds (NA1-115-7), isolated from Zygogynum pancheri, a plant belonging to the Winteraceae family. NA1-115-7 specifically induced the apoptosis of MCL-1-dependent tumor cells, with two hours of treatment sufficient to trigger cell death. The treatment of lymphoma cells with NA1-115-7 stabilized MCL-1, disrupted its interactions with BAK, and rapidly induced apoptosis through a BAK- and BAX-mediated process. Importantly, a similar treatment with NA1-115-7 was not toxic to erythrocytes, peripheral blood mononuclear cells, platelets, or cardiomyocytes. These results highlight the potential of natural products for use as specific BH3 mimetics non-toxic to normal cells, and they suggest that NA1-115-7 may be a promising tool for use in cancer treatment.


Subject(s)
Antineoplastic Agents , Hematologic Neoplasms , Antineoplastic Agents/pharmacology , Apoptosis , Bridged Bicyclo Compounds, Heterocyclic , Cell Line, Tumor , Hematologic Neoplasms/drug therapy , Humans , Leukocytes, Mononuclear/metabolism , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Myocytes, Cardiac/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Sulfonamides , Winteraceae/metabolism , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-X Protein/metabolism
5.
ChemMedChem ; 16(11): 1788-1797, 2021 06 07.
Article in English | MEDLINE | ID: mdl-33665938

ABSTRACT

Drimane sesquiterpenoid dialdehydes are natural compounds with antiproliferative properties. Nevertheless, their mode of action has not yet been discovered. Herein, we demonstrate that various drimanes are potent inhibitors of MCL-1 and BCL-xL, two proteins of the BCL-2 family that are overexpressed in various cancers, including lymphoid malignancies. Subtle changes in their structure significantly modified their activity on the target proteins. The two most active compounds are MCL-1 selective and bind in the BH3 binding groove of the protein. Complementary studies by NMR spectroscopy and mass spectrometry analyses, but also synthesis, showed that they covalently inhibit MCL-1 though the formation of a pyrrole adduct. In addition, cytotoxic assays revealed that these two compounds show a cytotoxic selectivity for BL2, a MCL-1/BCL-xL-dependent cell line and induce apoptosis.


Subject(s)
Antineoplastic Agents/pharmacology , Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors , Polycyclic Sesquiterpenes/pharmacology , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/chemistry , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cell Survival/drug effects , Dose-Response Relationship, Drug , Drug Screening Assays, Antitumor , Humans , Molecular Structure , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Polycyclic Sesquiterpenes/chemical synthesis , Polycyclic Sesquiterpenes/chemistry , Protein Domains/drug effects , Structure-Activity Relationship , bcl-2-Associated X Protein/antagonists & inhibitors , bcl-2-Associated X Protein/metabolism
6.
J Nat Prod ; 83(10): 3069-3079, 2020 10 23.
Article in English | MEDLINE | ID: mdl-33016067

ABSTRACT

A unique collection of 292 extracts from 107 New Caledonian Euphorbiaceae species sensu lato was profiled by LC-MS2 and the metabolite content organized by molecular networking. Based on the assumption that taxon-specific molecules are more likely to be structurally novel, taxonomic data were mapped on spectral networks to detect genus-specific clusters. Using this approach, a group of compounds unique to the genus Austrobuxus was highlighted. The subsequent MS-guided purification of the fruit EtOAc extract of Austrobuxus carunculatus led to the isolation of 13 new monolactone and "norditerpene" picrotoxanes (2-14), along with the known tutin (1). The structures of the new compounds were elucidated by HRESIMS and NMR spectroscopic data analysis, and the absolute configurations of compounds 1, 3, 7, 11, 12, and 14 were determined by single-crystal X-ray diffraction analysis. The relative and absolute configurations of compounds 4 and 5 were ascertained by chemical transformation of compound 3. The absolute configurations of other members of the series have been proposed on the basis of biogenetic considerations and specific rotation values of similar sign and magnitude. Compounds 1-14 were evaluated for their antiproliferative activities against HCT116 colon, U87-MG glioblastoma, and A549 lung human cancer cell lines. Compounds bearing an acyl chain at C-2 (i.e., 2, 4, and 13) showed IC50 values in the micromolar range for the three cell lines used.


Subject(s)
Antineoplastic Agents, Phytogenic/isolation & purification , Euphorbiaceae/chemistry , Euphorbiaceae/classification , Antineoplastic Agents, Phytogenic/chemistry , Antineoplastic Agents, Phytogenic/pharmacology , Cell Line, Tumor , Cell Proliferation/drug effects , Classification , Diterpenes , Humans , Magnetic Resonance Spectroscopy , Mass Spectrometry , Metabolic Networks and Pathways , Molecular Structure , Plant Extracts/chemistry , Plant Extracts/pharmacology , Spectrometry, Mass, Electrospray Ionization , Structure-Activity Relationship , X-Ray Diffraction
7.
Bioorg Med Chem Lett ; 30(7): 127003, 2020 04 01.
Article in English | MEDLINE | ID: mdl-32035700

ABSTRACT

A library of 26 novel carboxamides deriving from natural fislatifolic acid has been prepared. The synthetic strategy involved a bio-inspired Diels-Alder cycloaddition, followed by functionalisations of the carbonyl moiety. All the compounds were evaluated on Bcl-xL, Mcl-1 and Bcl-2 proteins. In this series of cyclohexenyl chalcone analogues, six compounds behaved as dual Bcl-xL/Mcl-1 inhibitors in micromolar range and one exhibited sub-micromolar affinities toward Mcl-1 and Bcl-2. The most potent compounds evaluated on A549 and MCF7 cancer cell lines showed moderate cytotoxicities.


Subject(s)
Amides/pharmacology , Antineoplastic Agents/pharmacology , Cyclohexanecarboxylic Acids/pharmacology , Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors , bcl-X Protein/antagonists & inhibitors , Amides/chemical synthesis , Antineoplastic Agents/chemical synthesis , Apoptosis/drug effects , Cell Line, Tumor , Cyclohexanecarboxylic Acids/chemical synthesis , Drug Screening Assays, Antitumor , Humans , Small Molecule Libraries/chemical synthesis , Small Molecule Libraries/pharmacology , Stereoisomerism
8.
J Biol Chem ; 295(13): 4277-4288, 2020 03 27.
Article in English | MEDLINE | ID: mdl-32075908

ABSTRACT

ORPphilins are bioactive natural products that strongly and selectively inhibit the growth of some cancer cell lines and are proposed to target intracellular lipid-transfer proteins of the oxysterol-binding protein (OSBP) family. These conserved proteins exchange key lipids, such as cholesterol and phosphatidylinositol 4-phosphate (PI(4)P), between organelle membranes. Among ORPphilins, molecules of the schweinfurthin family interfere with intracellular lipid distribution and metabolism, but their functioning at the molecular level is poorly understood. We report here that cell line sensitivity to schweinfurthin G (SWG) is inversely proportional to cellular OSBP levels. By taking advantage of the intrinsic fluorescence of SWG, we followed its fate in cell cultures and show that its incorporation at the trans-Golgi network depends on cellular abundance of OSBP. Using in vitro membrane reconstitution systems and cellular imaging approaches, we also report that SWG inhibits specifically the lipid transfer activity of OSBP. As a consequence, post-Golgi trafficking, membrane cholesterol levels, and PI(4)P turnover were affected. Finally, using intermolecular FRET analysis, we demonstrate that SWG directly binds to the lipid-binding cavity of OSBP. Collectively these results describe SWG as a specific and intrinsically fluorescent pharmacological tool for dissecting OSBP properties at the cellular and molecular levels. Our findings indicate that SWG binds OSBP with nanomolar affinity, that this binding is sensitive to the membrane environment, and that SWG inhibits the OSBP-catalyzed lipid exchange cycle.


Subject(s)
Biological Transport/drug effects , Lipids/genetics , Receptors, Steroid/metabolism , Stilbenes/metabolism , Carrier Proteins/chemistry , Carrier Proteins/genetics , Endoplasmic Reticulum/chemistry , Endoplasmic Reticulum/genetics , Fluorescence , Humans , Lipids/chemistry , Protein Binding/genetics , Protein Transport/genetics , Receptors, Steroid/chemistry , Stilbenes/chemistry , trans-Golgi Network/chemistry , trans-Golgi Network/genetics
9.
Int J Mol Sci ; 20(5)2019 Mar 02.
Article in English | MEDLINE | ID: mdl-30832353

ABSTRACT

A biological evaluation of a library of extracts from entomopathogen strains showed that Pantoea sp. extract has significant antimicrobial and insecticidal activities. Three hydroxyacyl-phenylalanine derivatives were isolated from this strain. Their structures were elucidated by a comprehensive analysis of their NMR and MS spectroscopic data. The antimicrobial and insecticidal potencies of these compounds were evaluated, and compound 3 showed 67% mortality against Aedes aegypti larvae at a concentration of 100 ppm, and a minimum inhibitory concentration (MIC) of 16 µg/mL against methicillin-resistant Staphylococcus aureus. Subsequently, hydroxyacyl-phenylalanine analogues were synthesized to better understand the structure-activity relationships within this class of compounds. Bioassays highlighted the antimicrobial potential of analogues containing saturated medium-chain fatty acids (12 or 14 carbons), whereas an unsaturated long-chain fatty acid (16 carbons) imparted larvicidal activity. Finally, using a molecular networking-based approach, several close analogues of the isolated and newly synthesized lipoamino acids were discovered in the Pantoea sp. extract.


Subject(s)
Anti-Infective Agents/chemistry , Fatty Acids/chemistry , Insecticides/chemistry , Pantoea/chemistry , Aedes/drug effects , Animals , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/pharmacology , Fatty Acids/chemical synthesis , Fatty Acids/pharmacology , Insecticides/chemical synthesis , Insecticides/pharmacology , Methicillin-Resistant Staphylococcus aureus/drug effects , Structure-Activity Relationship
10.
J Nat Prod ; 81(4): 901-912, 2018 04 27.
Article in English | MEDLINE | ID: mdl-29493237

ABSTRACT

Bioassay-guided fractionation of an EtOAc extract of the trunk bark of Sandwithia guyanensis, using a chikungunya virus (CHIKV)-cell-based assay, afforded 17 new diterpenoids 1-17 and the known jatrointelones A and C (18 and 19). The new compounds included two tetranorditerpenoids 1 and 2, a trinorditerpenoid 3, euphoractines P-W (4-11), and euphactine G (13) possessing the rare 5/6/7/3 (4-7), 5/6/6/4 (8-11), and 5/6/8 (13) fused ring skeletons, sikkimenoid E (12), and jatrointelones J-M (14-17) possessing jatropholane and lathyrane carbon skeletons, respectively. Jatrointelones J (14) and M (17) represent the first naturally occurring examples of C-15 nonoxidized lathyrane-type diterpenoids. The structures of the new compounds were elucidated by NMR spectroscopic data analysis. The relative configuration of compound 16 and the absolute configurations of compounds 3-6 and 14 were determined by single-crystal X-ray diffraction analysis. In addition, jatrointelone K (15) was chemically transformed to euphoractine T (8) supporting the biosynthetic relationships between the two types of diterpenoids. Only compound 15 showed a moderate anti-CHIKV activity with an EC50 value of 14 µM. Finally, using a molecular networking-based dereplication strategy, several close analogues of 12- O-tetradecanoylphorbol-13-acetate (TPA), one of the most potent inhibitors of CHIKV replication, were dereplicated.


Subject(s)
Diterpenes/chemistry , Euphorbiaceae/chemistry , Antiviral Agents/chemistry , Antiviral Agents/pharmacology , Chikungunya virus/drug effects , Crystallography, X-Ray/methods , DNA Replication/drug effects , Diterpenes/pharmacology , Virus Replication/drug effects
11.
Eur J Med Chem ; 148: 26-38, 2018 Mar 25.
Article in English | MEDLINE | ID: mdl-29453135

ABSTRACT

Thirty analogues of natural meiogynin A, a pan-Bcl-2 inhibitor, were prepared in order to elaborate cytotoxic compounds on specific cancer cells overexpressing one or more proteins of the Bcl-2 family. The interaction of all the new analogues with Bcl-xL, Mcl-1 and Bcl-2 proteins was first evaluated by fluorescence polarization assay (FPA) and showed that modulation of the lateral chain has a dramatic impact as subtle changes significantly modify the activity on the target proteins. The acetoxymethyl prodrugs of the two most active compounds were then elaborated to determine their cytotoxicity on B cell lines. A strong cytotoxic effect on BL2, RS4;11 and H929 cells was observed with a triazole prodrug that induces apoptosis.


Subject(s)
Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , Sesquiterpenes/chemistry , Apoptosis/drug effects , Apoptosis Regulatory Proteins/antagonists & inhibitors , B-Lymphocytes/drug effects , Cell Line, Tumor , Fluorescence Polarization Immunoassay , Humans , Prodrugs/chemistry , Prodrugs/pharmacology , Structure-Activity Relationship , bcl-X Protein
12.
Org Biomol Chem ; 15(26): 5585-5592, 2017 Jul 05.
Article in English | MEDLINE | ID: mdl-28639654

ABSTRACT

Thermic dimerization of methyl 1,3-cyclohexadiene 2-carboxylate gave original 3D-shape compounds by Diels-Alder cycloaddition and original [6 + 4]-ene reaction. Further selective modifications on an endo [4 + 2] cycloadduct via a diversity oriented synthesis (DOS) strategy quickly led to the preparation of a small library of original 3D scaffolds, providing access to a larger and unexplored chemical space for drug discovery processes.

13.
Org Biomol Chem ; 13(19): 5520-31, 2015 May 21.
Article in English | MEDLINE | ID: mdl-25877523

ABSTRACT

The synthesis, on a large scale, with very good yield and er via an efficient strategy, of a chiral 4-substituted 2-cyclohexenone intermediate, was a milestone in the synthesis of seven analogues of meiogynin A, a natural sesquiterpenoid dimer. These compounds were elaborated in ten linear steps. Their binding affinities for Bcl-xL and Mcl-1, two proteins of the Bcl-2 family, overexpressed in various types of cancers, were evaluated. This enabled to further SAR studies en route to the elaboration of potent dual inhibitors of anti-apoptotic proteins of the Bcl-2 family.


Subject(s)
Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors , Sesquiterpenes/pharmacology , bcl-X Protein/antagonists & inhibitors , Aldehydes/chemistry , BH3 Interacting Domain Death Agonist Protein/antagonists & inhibitors , BH3 Interacting Domain Death Agonist Protein/metabolism , Chromatography, High Pressure Liquid , Cyclohexanones/chemical synthesis , Cyclohexanones/chemistry , Ligands , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Naphthalenes/chemistry , Sesquiterpenes/chemical synthesis , Sesquiterpenes/chemistry , bcl-2 Homologous Antagonist-Killer Protein/antagonists & inhibitors , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-X Protein/metabolism
14.
Bioorg Med Chem Lett ; 24(21): 5086-8, 2014 Nov 01.
Article in English | MEDLINE | ID: mdl-25266781

ABSTRACT

The biological evaluation of a natural sesquiterpene dimer meiogynin A 1, is described as well as that of five non-natural analogues. Although active on a micromolar range on the inhibition of Bcl-xL/Bak and Mcl-1/Bid interaction, meiogynin A 1 is not cytotoxic on three cell lines that overexpress Bcl-xL and Mcl-1. Contrarily, one of its analogues 6 with an inverted configuration on the side chain and an aromatic moiety replacing the cyclohexane ring was active on both target proteins, cytotoxic on a micromolar range and was found to induce apoptosis through a classical pathway.


Subject(s)
Benzoates/chemistry , Myeloid Cell Leukemia Sequence 1 Protein/metabolism , Naphthalenes/chemistry , Sesquiterpenes/chemistry , bcl-X Protein/metabolism , Apoptosis/drug effects , BH3 Interacting Domain Death Agonist Protein/antagonists & inhibitors , BH3 Interacting Domain Death Agonist Protein/metabolism , Benzoates/chemical synthesis , Benzoates/pharmacology , Binding Sites , Cell Line, Tumor , Cell Survival/drug effects , Humans , Molecular Docking Simulation , Myeloid Cell Leukemia Sequence 1 Protein/antagonists & inhibitors , Naphthalenes/chemical synthesis , Naphthalenes/pharmacology , Poly(ADP-ribose) Polymerases/metabolism , Protein Structure, Tertiary , Sesquiterpenes/chemical synthesis , Sesquiterpenes/pharmacology , bcl-2 Homologous Antagonist-Killer Protein/antagonists & inhibitors , bcl-2 Homologous Antagonist-Killer Protein/metabolism , bcl-X Protein/antagonists & inhibitors
15.
Chemistry ; 20(29): 8918-22, 2014 Jul 14.
Article in English | MEDLINE | ID: mdl-24961599

ABSTRACT

Carboxylate anions, dianions and ester enolates provide simultaneous protection and activation for directed carbometalation reactions. Advantage can be taken of the bis-carbanionic character of the intermediate for further controlled C-C bond forming reactions.

16.
J Org Chem ; 74(17): 6728-34, 2009 Sep 04.
Article in English | MEDLINE | ID: mdl-19637842

ABSTRACT

We herein described an intramolecular imino Diels-Alder reaction promoted with BF(3).OEt(2)/DDQ affording substituted quinolines. Using this procedure, we prepared the chiral quinoline moiety of the uncialamycin, a new enediyne natural product.


Subject(s)
Anthraquinones/chemistry , Anthraquinones/chemical synthesis , Chemistry, Organic/methods , Alkenes/chemistry , Alkynes/chemistry , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/pharmacology , Chemistry, Pharmaceutical/methods , Models, Chemical , Molecular Structure , Oxygen/chemistry , Quinolines/chemistry , Stereoisomerism , X-Ray Diffraction
SELECTION OF CITATIONS
SEARCH DETAIL